Collectively, our data suggest that concomitant triggering of CD137 and blocking of PD-1 signalling within irradiated melanomas enhance the intratumoral presence of both CD4+ and CD8+ T cells, which are in part required for melanoma Control. The gene discussed is TNFRSF9; the disease is melanoma.